HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ravaglia, G. Articles by Mecocci, P. Search for Related Content PubMed PubMed Citation Articles by Ravaglia, G. Articles by Mecocci, P. Agricola Articles by Ravaglia, G. Articles by Mecocci, P.

Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort^1,2,3

¹ From the Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy (GR, PF, AL, NP, and ER); the Institute of Gerontology and Geriatrics, Perugia University Hospital, Perugia, Italy (FM, RC, and PM); and the Department of Medicine, McMaster University, Hamilton, ON, Canada (CP)

Background: Evidence that vitamin E may preserve cognitive function in elderly subjects is conflicting. The most abundant and most investigated form of vitamin E in humans is -tocopherol, but other antioxidant tocopherols (β, , and ) exist in nature.

Objective: We aimed to investigate plasma concentrations of the natural tocopherols and the tocopherol oxidation markers -tocopherylquinone (TQ) and 5-nitro--tocopherol (5NGT) in relation to cognitive function in the elderly.

Design: Baseline plasma tocopherols and their oxidation markers were measured in 761 elderly Italian subjects from a population-based cohort assessed in 1999–2000 for mild cognitive impairment (MCI) and dementia. In 2003–2004, information about cognitive status was collected for 615 of the 666 subjects without baseline cognitive impairment. Tocopherols and oxidation markers were analyzed as plasma absolute values divided by serum total cholesterol because lipids affect their blood availability. Analyses were adjusted for sociodemographic, genetic, lifestyle, and medical confounders.

Results: Compared with the corresponding lowest tertile, the risk of prevalent dementia was higher for the highest tertile of -tocopherol÷cholesterol [odds ratio (OR): 3.87; 95% CI: 1.46, 10.27] and TQ÷cholesterol (4.02; 1.45, 11.14), but the risk of incident dementia was not directly associated with plasma vitamin E metabolites. A U-shaped association, with lower risk for intermediate tertiles, was found for prevalent MCI with 5NGT÷cholesterol (0.39; 0.17, 0.91) and for incident dementia with -tocopherol÷cholesterol (hazard ratio: 0.42; 95% CI: 0.22, 0.84).

Conclusions: Plasma concentrations of some non--tocopherol forms of vitamin E are associated with cognitive impairment in elderly people. However, the associations depend on concurrent cholesterol concentration and need further investigation.

This article has been cited by other articles:

				C. K. Chow Plasma tocopherols and the risk of cognitive impairment Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1447 - 1448. [Full Text] [PDF]